This focused issue on “Improving Outcomes in Lung Cancer through Early Diagnosis and Smoking Cessation” is edited by Dr. Alfredo Tartarone, Division of Medical Oncology, Department of Onco-Hematology, IRCCS-CROB Referral Cancer Center of Basilicata, Rionero in Vulture (Pz), Italy.
Dr. Tartarone, graduated in Medicine at the Federico II University of Naples Italy in 1993. In 1998, he achieved a postgraduate specialization in Medical Oncology at the Catholic University of Rome. He is presently medical executive at the Department of Onco-Hematology of the Referral Cancer Center of Basilicata, IRCCS-CROB, Rionero in Vulture, Italy. His main scientific interest includes the medical treatment of lung cancer. Dr. Tartarone is a member of the European Society for Medical Oncology (ESMO), the Italian Association of Medical Oncology (AIOM) and the Italian Association of Thoracic Oncology (AIOT).
Focused issue outline:
- The importance of smoking cessation and lung cancer screening
- Liquid biopsy in early lung cancer detection
- Possible role of circulating tumor cells (CTCs) in early lung cancer detection
- Methodology of curriculum development
- Intervention programmes to implement tobacco control policies and smoking cessation
- Electronic nicotine delivery systems (ENDS): pros and cons
- Behavioural and pharmacological treatment for smoking cessation
- The WALCE (Women Against Lung Cancer in Europe) experience
- Cardiovascular risk of smoking and benefits of smoking cessation